Search
Now showing items 1-5 of 5
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients
(2020)
Purpose: To evaluate the distribution of metastatic lymph nodes (LN) detected on Ga-68-PSMA-positron emission tomography/computed tomography (PET/CT) in treatment-naive prostate cancer (PC) patients and to analyze the LN ...
The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy
(2022)
Purpose: To assess the correlation between initial tumor apparent diffusion coefficient (ADC) values and clinicopathological parameters in prostate cancer (PCa) patients treated with definitive radiotherapy (RT). Additionally, ...
Retrospective correlation of (68)ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy
(2020)
Objective The aim of the study is to investigate the correlation between the intensity of prostate-specific membrane antigen (PSMA) uptake in primary tumor and clinico-pathological characteristics of non-metastatic prostate ...
Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients
(2020)
Purpose To compare the incidental testicular doses during volumetric-modulated arc therapy (VMAT) in patients receiving prostate-only and pelvic lymphatic irradiation. Materials and methods Testicular doses in 40 intermediate- ...
Prostate Mucinous Carcinoma Treated with Definitive Radiotherapy and Hormonal Therapy: Case Report and Review of the Literature
(2014)
Prostate mucinous carcinoma (MC) is a rare variant of prostate adenocarcinoma that is characterized by large pools of extracellular mucin, which by definition compose at least 25% of the tumor volume.
Prostate MC has 3 ...
